the efficacy for type 2 Diabetes of Repaglinide taking twice or three times a day
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000006855
- Lead Sponsor
- Graduate School of Medicine, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.type 1 diabetes 2.severe liver dysfunction 3.severe renal dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method